Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Shimada

Showing results (41-50 of 824) with videos related to

Pageof 83
Sort By:
Cardiology in the Young|July 31, 2025
Persistent complete atrioventricular block in an infant with Kawasaki disease: a rare case reportHiroyuki Shimada, Hidenori Yamamoto, Shinya Hara
Archives of Gerontology and Geriatrics|March 8, 2024
Prediction of decline in activities of daily living using motor performance tests in older adults requiring long-term careShinnosuke Hato, Yuta Hayashi, Hiroyuki Shimada
International Ophthalmology|July 4, 2017
Comparative study of 27-gauge and 25-gauge vitrectomy performed as day surgeryRyusaburo Mori, Saigen Naruse, Hiroyuki Shimada
European Journal of Ophthalmology|July 15, 2017
Comments to: Povidone-Iodine 3-Minute Exposure Time is Viable in Preparation for Cataract SurgeryHiroyuki Shimada, Hiroyuki Nakashizuka, Andrzej Grzybowski
Human Pathology|February 18, 2014
Neuroblastoma or not neuroblastomaRisa Teshiba, Herve Sartelet, Hiroyuki Shimada
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic TumorsKlaus Beiske, Naohiko Ikegaki, Hiroyuki Shimada
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|July 18, 2012
[Pathology of peripheral neuroblastic tumors]Larry Wang, Le-jian He, Hiroyuki Shimada
Current Oncology (Toronto, Ont.)|June 26, 2024
A Perspective on the CD47-SIRPA Axis in High-Risk NeuroblastomaXao X Tang, Hiroyuki Shimada, Naohiko Ikegaki
Virchows Archiv : an International Journal of Pathology|March 29, 2025
Peripheral neuroblastic tumors behaving badly: an update on high-risk morphologic and molecular groupingsJason A Jarzembowski, Samuel Navarro, Hiroyuki Shimada
Frontiers in Immunology|May 10, 2021
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk NeuroblastomaXao X Tang, Hiroyuki Shimada, Naohiko Ikegaki
Pageof 83

Showing results (41-50 of 824) with videos related to

Sort By:
Pageof 83
Cardiology in the Young|July 31, 2025
Persistent complete atrioventricular block in an infant with Kawasaki disease: a rare case reportHiroyuki Shimada, Hidenori Yamamoto, Shinya Hara
Archives of Gerontology and Geriatrics|March 8, 2024
Prediction of decline in activities of daily living using motor performance tests in older adults requiring long-term careShinnosuke Hato, Yuta Hayashi, Hiroyuki Shimada
International Ophthalmology|July 4, 2017
Comparative study of 27-gauge and 25-gauge vitrectomy performed as day surgeryRyusaburo Mori, Saigen Naruse, Hiroyuki Shimada
European Journal of Ophthalmology|July 15, 2017
Comments to: Povidone-Iodine 3-Minute Exposure Time is Viable in Preparation for Cataract SurgeryHiroyuki Shimada, Hiroyuki Nakashizuka, Andrzej Grzybowski
Human Pathology|February 18, 2014
Neuroblastoma or not neuroblastomaRisa Teshiba, Herve Sartelet, Hiroyuki Shimada
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic TumorsKlaus Beiske, Naohiko Ikegaki, Hiroyuki Shimada
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|July 18, 2012
[Pathology of peripheral neuroblastic tumors]Larry Wang, Le-jian He, Hiroyuki Shimada
Current Oncology (Toronto, Ont.)|June 26, 2024
A Perspective on the CD47-SIRPA Axis in High-Risk NeuroblastomaXao X Tang, Hiroyuki Shimada, Naohiko Ikegaki
Virchows Archiv : an International Journal of Pathology|March 29, 2025
Peripheral neuroblastic tumors behaving badly: an update on high-risk morphologic and molecular groupingsJason A Jarzembowski, Samuel Navarro, Hiroyuki Shimada
Frontiers in Immunology|May 10, 2021
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk NeuroblastomaXao X Tang, Hiroyuki Shimada, Naohiko Ikegaki
Pageof 83